The weight loss medication should not be used alongside other GLP-1 receptor agonists, such as Mounjaro or liraglutide, due to increased side-effect risk
The dose schedule outlines the standard four-week intervals used in clinical trials
These mistakes appear repeatedly and undermine results
For these patients, the tirzepatide interaction is particularly complex because their target TSH is already below normal, and further suppression could increase cardiovascular risk without providing additional cancer protection
A healthcare provider can evaluate whether continuing Retatrutide makes sense and may suggest modifications to your protocol
With one dissenting vote, commissioners separately agreed to move forward with their meeting and not tackle other plan design changes that staff had recommended, including raising copays and deductibles